BHWM
RYTM icon

Bay Harbor Wealth Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bay Harbor Wealth Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86 Hold
1
– – ﹤0.01% 1224
2025
Q4 		$107 Buy
+1
New +$106 ﹤0.01% 1201

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Bay Harbor Wealth Management's RYTM Position: Q1 2026 in Review

Bay Harbor Wealth Management held its Rhythm Pharmaceuticals (RYTM) position steady in Q1 2026 at 1 share worth $86. The position accounts for ﹤0.01% of the portfolio, ranked #1224.

Bay Harbor Wealth Management first reported a position in RYTM in Q4 2025 and has held it in 2 quarters since. The position peaked at $107 in Q4 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Bay Harbor Wealth Management held 1 share of Rhythm Pharmaceuticals worth $86 as of Q1 2026.
  • Bay Harbor Wealth Management left its Rhythm Pharmaceuticals share count unchanged in Q1 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q1 2026, its #1224 holding.
  • Bay Harbor Wealth Management first reported a position in Rhythm Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Bay Harbor Wealth Management's Rhythm Pharmaceuticals position peaked at $107 in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q1 2026, filed 14 Apr 2026.